Titan Medical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Titan Medical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	16.3%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Titan Medical reports Q2 results

Aug 11

Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule

Jun 29

Titan Medical: Developing Single-Access Robotic Assisted Surgical Technologies

Dec 05

Titan Medical earns milestone payment of $10M under licensing deal with Medtronic; shares rise 10%

May 28

Titan Medical announces $15M bought deal offering

Feb 02

Titan Medical announces $10M bought deal offering

Jan 05

Titan medical provides regulatory update on its Enos Robotic Single Access System

Dec 30

Titan Medical in full compliance with Nasdaq listing criteria

Dec 24

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Titan Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:TMDI.F - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	18	7	4	5	N/A
9/30/2023	17	-2	-3	-3	N/A
6/30/2023	17	-12	-9	-9	N/A
3/31/2023	N/A	-36	-28	-28	N/A
12/31/2022	N/A	-43	-29	-28	N/A
9/30/2022	10	-21	-33	-32	N/A
6/30/2022	10	-19	-35	-34	N/A
3/31/2022	20	-9	-26	-25	N/A
12/31/2021	20	-15	-37	-37	N/A
9/30/2021	20	-45	-25	-24	N/A
6/30/2021	20	-38	-19	-19	N/A
3/31/2021	20	-38	-12	-12	N/A
12/31/2020	20	-24	-1	-1	N/A
9/30/2020	10	-1	-3	-3	N/A
6/30/2020	10	-1	-10	-10	N/A
3/31/2020	N/A	-14	-30	-29	N/A
12/31/2019	N/A	-42	-46	-46	N/A
9/30/2019	N/A	-53	-62	-62	N/A
6/30/2019	N/A	-59	-62	-61	N/A
3/31/2019	N/A	-50	-55	-55	N/A
12/31/2018	N/A	-23	-42	-41	N/A
9/30/2018	N/A	-27	-29	-29	N/A
6/30/2018	N/A	-33	-24	-24	N/A
3/31/2018	N/A	-29	-21	-21	N/A
12/31/2017	N/A	-34	-19	-19	N/A
9/30/2017	N/A	-23	N/A	-17	N/A
6/30/2017	N/A	-11	N/A	-18	N/A
3/31/2017	N/A	-17	N/A	-21	N/A
12/31/2016	N/A	-23	N/A	-35	N/A
9/30/2016	N/A	-34	N/A	-42	N/A
6/30/2016	N/A	-44	N/A	-45	N/A
3/31/2016	N/A	-44	N/A	-46	N/A
12/31/2015	N/A	-41	N/A	-34	N/A
9/30/2015	N/A	-28	N/A	-29	N/A
6/30/2015	N/A	-20	N/A	-24	N/A
3/31/2015	N/A	-19	N/A	-18	N/A
12/31/2014	N/A	-13	N/A	-13	N/A
9/30/2014	N/A	-16	N/A	-10	N/A
6/30/2014	N/A	-15	N/A	-7	N/A
3/31/2014	N/A	-10	N/A	-8	N/A
12/31/2013	N/A	-9	N/A	-8	N/A
9/30/2013	N/A	-8	N/A	-7	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if TMDI.F's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if TMDI.F's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if TMDI.F's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if TMDI.F's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if TMDI.F's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if TMDI.F's Return on Equity is forecast to be high in 3 years time

Titan Medical Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Conavi Medical Inc. entered into a definitive amalgamation agreement to acquire Titan Medical Inc. (TSX:TMD) in a reverse merger transaction.

Titan Medical Inc. to Report Fiscal Year 2023 Results on Mar 29, 2024

Titan Medical Inc. Appoints Daniel O’Brien as A New Independent Member to Its Board of Directors

Titan Medical Inc. Announces Executive Terminations

Titan Medical Announces Receipt of Nasdaq Listing Determination

High number of new and inexperienced directors

Third quarter 2022 earnings released: US$0.09 loss per share (vs US$0.077 loss in 3Q 2021)

Titan Medical Inc. to Report Q3, 2022 Results on Nov 10, 2022

Titan Medical Inc. Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted Surgery

First half 2022 earnings released

Titan Medical reports Q2 results

High number of new and inexperienced directors

Titan Medical Inc. to Report Q2, 2022 Results on Aug 11, 2022

Titan Medical Inc. Announces Management Changes, Effective July 1, 2022

Titan Medical Gets 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule

Titan Medical Provides Update to Enos Project Timeline

Titan Medical Announces Departure of Perry Genova, Senior Vice President of Research and Product Development

Titan Medical Inc., Annual General Meeting, Jun 08, 2022

Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing Strategy

Titan Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Titan Medical: Developing Single-Access Robotic Assisted Surgical Technologies

Titan Medical earns milestone payment of $10M under licensing deal with Medtronic; shares rise 10%

Titan Medical Inc. has completed a Composite Units Offering in the amount of $20.004 million.

Titan Medical Inc. to Report Q4, 2020 Results on Feb 22, 2021

Titan Medical announces $15M bought deal offering

Titan Medical announces $10M bought deal offering

Titan Medical Inc. Provides Regulatory Update

Titan medical provides regulatory update on its Enos Robotic Single Access System

Titan Medical in full compliance with Nasdaq listing criteria

Titan Medical Provides Update on Medtronic Development and License Agreement

Titan Medical Inc. Announces Board Appointments

Titan Medical Inc. Approves Election of Directors

Titan Medical Inc Announces the Launch of A New Name and Brand Identity for Its Robotic Surgical System Under Development

Titan Medical Confirms Receipt of Deficiency Notice from Nasdaq

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies